Neutrophil-to-Lymphocyte Ratio in Chronic Obstructive Pulmonary Disease: A Retrospective Study
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global Initiative for Chronic Obstructive Lung Disease
Gerald, L. B., & Bailey, W. C. (2002) · Journal of Cardiopulmonary Rehabilitation · doi:10.1097/00008483-200207000-00004 · Cited by 5,830
Celli, B. R., MacNee, W., Agusti, A., Anzueto, A., Berg, B., Buist, A. S., Calverley, P. M. A., Chavannes, N., Dillard, T., Fahy, B., et al. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00014304 · Cited by 4,421
The Pathophysiology and Treatment of Sepsis
Hotchkiss, R. S., & Karl, I. E. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021333 · Cited by 4,097 · cited 2×
“Leukocyte count and its subtypes have been reported as inflammatory markers in chronic inflammatory diseases [6, 9, 10].”
The Nature of Small-Airway Obstruction in Chronic Obstructive Pulmonary Disease
Hogg, J. C., Chu, F., Utokaparch, S., Woods, R., Elliott, W. M., Buzatu, L., Cherniack, R. M., Rogers, R. M., Sciurba, F. C., Coxson, H. O., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032158 · Cited by 3,782 · cited 1×
“lungs to inhaled noxious particles or gasses especially tobacco smoke [2, 3].”
Global Initiative for Chronic Obstructive Lung Disease (GOLD)
Rahman, M. M., & Siddiqui, M. M. R. (2017) · Anwer Khan Modern Medical College Journal · doi:10.3329/akmmcj.v7i1.31596 · Cited by 3,106
Antibiotic Therapy in Exacerbations of Chronic Obstructive Pulmonary Disease
ANTHONISEN, N. R., MANFREDA, J., WARREN, C. P. W., HERSHFIELD, E. S., HARDING, G. K. M., & NELSON, N. A. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-2-196 · Cited by 2,492 · cited 1×
“Acute exacerbation was defined as prolonged (≥48 h) worsening of dyspnea sensation, coughing, or sputum production leading to an increase in the use of maintenance medications and/or supplementation with additional medications [15].”
Gan, W. Q. (2004) · Thorax · doi:10.1136/thx.2003.019588 · Cited by 1,838 · cited 2×
“and leukocyte count are associated with COPD [5, 6].”
Systemic effects of chronic obstructive pulmonary disease
Agustí, A. G. N., Noguera, A., Sauleda, J., Sala, E., Pons, J., & Busquets, X. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00405703 · Cited by 1,045
Schols, A. M., Buurman, W. A., Staal van den Brekel, A. J., Dentener, M. A., & Wouters, E. F. (1996) · Thorax · doi:10.1136/thx.51.8.819 · Cited by 522 · cited 1×
“Furthermore, a low-grade inflammation that has been demonstrated by an increase in blood leukocyte levels, acutephase proteins, and other inflammatory cytokines is also associated with stable COPD [19].”
Núñez, J., Núñez, E., Bodí, V., Sanchis, J., Miñana, G., Mainar, L., Santas, E., Merlos, P., Rumiz, E., Darmofal, H., et al. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.11.004 · Cited by 510
Airway and Systemic Inflammation and Decline in Lung Function in Patients With COPD
Donaldson, G. C., Seemungal, T. A. R., Patel, I. S., Bhowmik, A., Wilkinson, T. M. A., Hurst, J. R., MacCallum, P. K., & Wedzicha, J. A. (2005) · Chest · doi:10.1378/chest.128.4.1995 · Cited by 480 · cited 1×
“CRP, which is one of the most popular and most studied markers in COPD, has been demonstrated to be related with disease severity, prognosis, diagnosis of acute exacerbations and complications [5, 8, 20, 21].”
C-reactive protein in patients with COPD, control smokers and non-smokers
Pinto-Plata, V. M. (2005) · Thorax · doi:10.1136/thx.2005.042200 · Cited by 435 · cited 1×
“of cardiovascular complications such as atherosclerosis [7].”
Inflammatory Biomarkers and Exacerbations in Chronic Obstructive Pulmonary Disease
Thomsen, M., Ingebrigtsen, T. S., Marott, J. L., Dahl, M., Lange, P., Vestbo, J., & Nordestgaard, B. G. (2013) · JAMA · doi:10.1001/jama.2013.5732 · Cited by 401 · cited 3×
“Leukocyte count and its subtypes have been reported as inflammatory markers in chronic inflammatory diseases [6, 9, 10].”
Turkmen, K., Erdur, F. M., Ozcicek, F., Ozcicek, A., Akbas, E. M., Ozbicer, A., Demirtas, L., Turk, S., & Tonbul, H. Z. (2013) · Hemodialysis International · doi:10.1111/hdi.12040 · Cited by 309
Neutrophil–Lymphocyte Ratio as a Predictor of Disease Severity in Ulcerative Colitis
Celikbilek, M., Dogan, S., Ozbakır, O., Zararsız, G., Kücük, H., Gürsoy, S., Yurci, A., Güven, K., & Yücesoy, M. (2013) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.21564 · Cited by 256
Neutrophil to Lymphocyte Ratio in Evaluation of Inflammation in Patients with Chronic Kidney Disease
Okyay, G. U., İnal, S., Öneç, K., Er, R. E., Paşaoğlu, Ö., Paşaoğlu, H., Derici, Ü., & Erten, Y. (2013) · Renal Failure · doi:10.3109/0886022x.2012.734429 · Cited by 206
As a New Inflammatory Marker for Familial Mediterranean Fever: Neutrophil-to-Lymphocyte Ratio
Ahsen, A., Ulu, M. S., Yüksel, Ş., Demir, K., Uysal, M., Erdoğan, M. Ö., & Acartürk, G. (2013) · Inflammation · doi:10.1007/s10753-013-9675-2 · Cited by 150 · cited 1×
“Leukocyte count and its subtypes have been reported as inflammatory markers in chronic inflammatory diseases [6, 9, 10].”
Self-citationRed Blood Cell Distribution and Survival in Patients with Chronic Obstructive Pulmonary Disease
Seyhan, E. C., Özgül, M. A., Tutar, N., Ömür, I. ̇., Uysal, A., & Altın, S. (2013) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2012.758697 · Cited by 147
Neutrophil gelatinase-associated lipocalin: a biomarker in COPD.
Eagan, T., Damås, J., Ueland, T., Voll-Aanerud, M., Mollnes, T., Hardie, J., Bakke, P., & Aukrust, P. (2010) · Chest · doi:10.1378/chest.09-2718 · Cited by 116 · cited 1×
“lungs to inhaled noxious particles or gasses especially tobacco smoke [2, 3].”
Ulaşlı, S. S., Özyürek, B. A., Yılmaz, E. B., & Ulubay, G. (2012) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.1284 · Cited by 102
Ertaş, G., Sönmez, O., Turfan, M., Kul, Ş., Erdoğan, E., Taşal, A., Bacaksız, A., Vatankulu, M. A., Altıntaş, Ö., Uyarel, H., et al. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.09.032 · Cited by 89 · cited 1×
“94 %) of the patients missing one or more data mentioned above and having a leukocyte count >12×10(3) cells/μl or <4×10(3) cells/μl were excluded from the study [13].”
Prognostic Value of Red Cell Distribution Width in Patients With Pulmonary Embolism
Özsu, S., Abul, Y., Günaydın, S., Örem, A., & Özlü, T. (2012) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029612464901 · Cited by 77
Red Cell Distribution Width in Patients with Obstructive Sleep Apnea Syndrome
Özsu, S., Abul, Y., Gülsoy, A., Bülbül, Y., Yaman, S., & Özlü, T. (2012) · Lung · doi:10.1007/s00408-012-9376-x · Cited by 74
Wang, R., Li, J., Cao, Z., & Li, Y. (2013) · Respirology · doi:10.1111/resp.12143 · Cited by 72 · cited 1×
“DecreasedMPV has been reported as an inflammatory marker in COPD patients in the literature [22, 23].”
Stockley, R. A. (2009) · Current Medical Research and Opinion · doi:10.1185/03007990902868971 · Cited by 67
Steiropoulos, P., Παπάνας, Ν., Nena, E., Xanthoudaki, M., Goula, T., Froudarakis, Μ. E., Pita, E., Maltezos, E. S., & Bouros, D. E. (2012) · Angiology · doi:10.1177/0003319712461436 · Cited by 65
Günay, E., Ulaşli, S. S., Kaçar, E., Halici, B., Ünlü, E., Tünay, K., Özkeçeci, G., Köken, T., & Ünlü, M. (2013) · The Clinical Respiratory Journal · doi:10.1111/crj.12031 · Cited by 63 · cited 1×
“PDW and P-LCR were analyzed from a histogram of platelet size distribution [16].”
Self-citationElevated levels of RDW is associated with non-valvular atrial fibrillation
Güngör, B., Özcan, K. S., Erdinler, I. C., Ekmekçi, A., Alper, A. T., Osmonov, D., Çalık, N., Akyüz, Ş., Toprak, E., Yılmaz, H. Y., et al. (2013) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-013-0957-1 · Cited by 62
Inflammatory Processes and Effects of Continuous Positive Airway Pressure (CPAP) in Overlap Syndrome
Nural, S., Günay, E., Halici, B., Celik, S., & Ünlü, M. (2012) · Inflammation · doi:10.1007/s10753-012-9520-z · Cited by 59 · cited 1×
“CRP, which is one of the most popular and most studied markers in COPD, has been demonstrated to be related with disease severity, prognosis, diagnosis of acute exacerbations and complications [5, 8, 20, 21].”
Self-citationSıncer, İ., Zorlu, A., Yılmaz, M. B., Doğan, Ö. T., Ege, M. R., Amioğlu, G., Aydın, G., Ardıç, İ., & Tandoğan, İ. (2011) · Heart & Lung · doi:10.1016/j.hrtlng.2011.07.011 · Cited by 53 · cited 1×
“[29] also reported that increased RDWmay be used to identify right ventricular failure in COPD patients.”
Antonescu-Turcu, A., & Tomic, R. (2009) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e3283218603 · Cited by 44 · cited 1×
“CRP, which is one of the most popular and most studied markers in COPD, has been demonstrated to be related with disease severity, prognosis, diagnosis of acute exacerbations and complications [5, 8, 20, 21].”
Cited by
Lan, C., Su, W., Yang, M., Chen, S., & Wu, Y. (2023) · Respirology · doi:10.1111/resp.14589 · Cited by 165
“Gunay et al. 11 first identified NLR as a rapid and easily measurable biomarker of inflammation severity in COPD patients.”
BackgroundValue of neutrophil/lymphocyte ratio in the differential diagnosis of sarcoidosis and tuberculosis
Iliaz, S., Iliaz, R., Ortakoylu, G., Bahadir, A., Bagci, B., & Caglar, E. (2014) · Annals of Thoracic Medicine · doi:10.4103/1817-1737.140135 · Cited by 89
Ye, Z., Ai, X., Liao, Z., You, C., & Cheng, Y. (2019) · Medicine · doi:10.1097/md.0000000000016371 · Cited by 57
Metadata
- Authors
- Günay, E., Sarınç Ulaşlı, S., Akar, O., Ahsen, A., Günay, S., Koyuncu, T., & Ünlü, M.
- Venue
- Inflammation
- Published
- 2013-09-28
- Volume
- 37
- Issue
- 2
- Pages
- 374-380
- ISSN
- 0360-3997 (ISSN-L)
- 1573-2576
- OpenAlex
- W2042814134
- Cited by
- 208
- References
- 31
- FWCI
- 10.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.